Delivery Order SPE2DB22D1106-SPE2DB25FEXR7
- Not listed
- The Defense Logistics Agency awarded a $3,003.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of May 20, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a $11,558.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of September 30, 2025, and represents a single delivery order fulfilling pharmaceutical supply needs for the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,001.17 firm fixed price delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 MG vial-diluents, with an ultimate completion date of September 5, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The award demonstrates continued federal reliance on AmerisourceBergen as a critical pharmaceutical distributor for military...
- The Defense Logistics Agency awarded a delivery order valued at $2,254.44 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of August 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal medical procurement and is performing the work at its corporate office...
- The Defense Logistics Agency awarded a $2,002.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with an ultimate completion date of June 30, 2025. This non-set-aside award was issued on June 27, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $17,310.31 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside contract supporting federal medical procurement requirements. The contract is performed from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $3,003.51 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract, issued on September 11, 2025, with completion targeted for September 12, 2025, utilizes firm fixed pricing and carries no set-aside designation. The award represents a competitive procurement action reflecting AmerisourceBergen's capability to fulfill federal pharmaceutical supply requirements. The place of performance is listed...
- The Defense Logistics Agency awarded a delivery order valued at $11,451.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of July 29, 2025, just one day following the award date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $3,003.51 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,003.51 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vivitrol is a medication used primarily in the treatment of alcohol and opioid use disorders, making this supply order critical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEXR7Delivery Order
The Defense Logistics Agency awarded a $3,003.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 MG vial-diluents, with an ultimate completion date of July 15, 2025. This non-set-aside contract represents a standalone delivery order for pharmaceutical supplies to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates consistent success in competing for open medical supply contracts with the DLA across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/14/25 |